After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
iBio Inc is listed on the AMEX in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of iBio Inc is $28.09M. A total of 1.2 million shares were traded on the day, compared to an average of 111.57K shares.
In the most recent transaction, Duran Felipe bought 9,191 shares of IBIO for 2.72 per share on Jan 10 ’25. After the transaction, the Chief Financial Officer now owns 11,139 company shares. In a previous transaction on Jan 10 ’25, Brenner Martin bought 9,191 shares at 2.72 per share. IBIO shares that the insider owns now total 18,316.
Among the insiders who bought shares, Banjak Marc acquired of 9,191 shares on Jan 10 ’25 at a per-share price of $2.72. This resulted in the Chief Legal Officer holding 11,066 shares of IBIO after the transaction. In another insider transaction, Arkowitz David bought 18,382 shares at $2.72 per share on Jan 10 ’25. Company shares held by the Director now total 18,382.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IBIO has a high of $4.98 and a low of $1.03.
As of this writing, IBIO has an earnings estimate of -$0.45 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.45.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IBIO’s latest balance sheet shows that the firm has $33.52M in Cash & Short Term Investments as of fiscal 2022. There were $25.77M in debt and $30.44M in liabilities at the time. Its Book Value Per Share was $2.06, while its Total Shareholder’s Equity was $63.48M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IBIO is Buy with a score of 5.00.
